Most Recent
Logistics services provider Qube has resolved a lawsuit that accused the Port of Newcastle of misusing its power in the market for port services by denying Qube's request to use its own equipment to provide dry bulk unloading services at the port.
Treasury Wine Estates has accused plaintiffs law firm Maurice Blackburn and barrister Guy Donnellan of "taking advantage" of their privileged position by using evidence discovered in a settled class action to file a second case against the wine maker.
Two psychiatrists at the heart of the Chelmsford deep sleep therapy scandal have had their defamation cases against publisher HarperCollins dismissed ,with a judge finding the lawsuits were an attempt to "rewrite history" regarding harm done to patients receiving their controversial treatment.
The High Court has declined to take up Mylan's challenge to a Full Court ruling upholding the invalidity of three patents for its blockbuster cholesterol drug Lipidil.
ANZ is gunning for a lawsuit alleging it dismissed a former director of trading after he complained about rate-rigging to be thrown out before trial.
A Sydney-based law firm is conducting a class action investigation into medical device manufacturer Boston Scientific's pelvic mesh products, adding to the growing list of companies facing lawsuit by women who claim they experienced pain and other adverse symptoms due to the implants.
A judge due to hear a high profile appeal by Johnson & Johnson unit Ethicon has expressed confusion about the grounds on which the medical device maker is challenging a landmark judgment putting it on the hook for potentially hundreds of million of dollars in damages over faulty pelvic mesh implants.
The Australian Taxation Office has secured a Full Federal Court victory in its $60 million tax battle with Healius, overturning a ruling that found the healthcare company could claw back a multi-million dollar tax refund.
The Federal Court has upheld Novartis' appeal of a ruling revoking its patent for an oral form of multiple sclerosis drug Gilenya, after Australian generic drug maker Arrow Pharmaceuticals dropped its opposition to the patent despite prevailing before IP Australia.
Engineering company Howden Australia can view the laptop and other electronic devices of an employee accused of stealing confidential information, after a judge found there was evidence suggesting the worker had not been "entirely truthful" with the court.